Clinical Trials Logo

Filter by:
NCT ID: NCT05477472 Completed - Major Depression Clinical Trials

Low Dose St John's Wort for Depression

Start date: August 2005
Phase:
Study type: Observational

This observational study observes the routine use of low-dose St John's Wort herbal mother tincture in patients with major depression. It measures intensity of depression at the beginning of St Johns Wort and after 6 weeks and evaluates tolerability and compliance.

NCT ID: NCT05475067 Completed - Clinical trials for Immune Response to mRNA COVID-19 Vaccination

Fever Tracking Study

Start date: October 7, 2021
Phase:
Study type: Observational

The aim of this study is to investigate the feasibility of continuous fever tracking of participants having fever symptoms in a home setting, using a core body temperature (CBT) sensor. CBT as measured by the wearable sensors will be coampared with CBT as measured by ingestible electronc pills (reference). A secondary research question is, if the CBT behavior of the the participants in a home setting can be compared to previously described CBT profiles in the literature, and if special patterns can be identified.

NCT ID: NCT05474170 Completed - Pediatric ALL Clinical Trials

Impact of 2 Resuscitation Sequences on Management of Simulated Pediatric Cardiac Arrest

Start date: September 1, 2022
Phase: N/A
Study type: Interventional

The International Liaison Committee on Resuscitation regularly publishes a Consensus on Science with Treatment Recommendations but guidelines can nevertheless differ when knowledge gaps persist. In case of pediatric cardiac arrest, the American Heart Association recommends following the adult resuscitation sequence i.e., starting with chest compressions. Conversely, the European Resuscitation Council advocates the delivery of 5 initial rescue breaths before starting chest compressions. Carrying out a randomized trial in children in cardiac arrest to assess the impact of these strategies would prove particularly challenging and ethical concerns may prevent such a trial from being performed. This will be a superiority, cross-over randomized trial whose goal is to determine the impact of these 2 resuscitation sequences on alveolar ventilation in a pediatric model of cardiac arrest. While not definitive, its results could help fill part of the current knowledge gap.

NCT ID: NCT05467423 Completed - Clinical trials for Iron Deficiency (Without Anemia)

Effect of Low-dose Versus Standard-dose Iron Supplementation on the Gut Microbiome

Start date: January 4, 2023
Phase: N/A
Study type: Interventional

Iron deficiency is a common problem that is often treated with the administration of oral iron. Most of the iron is not absorbed and remains in the intestine, where it influences the balance of gut bacteria. This influence is usually undesirable and should be kept as small as possible. With lower iron doses, the amount of unabsorbed iron is smaller and therefore a smaller change in the intestinal bacteria composition is to be expected.

NCT ID: NCT05461079 Completed - Infertility, Male Clinical Trials

Sperm Phenotype and Differentially Methylated Regions

Epigenetics
Start date: November 1, 2017
Phase:
Study type: Observational

Testicular dysgenesis syndrome (TDS) is known to cause epigenetic abnormalities in spermatozoa. Anogenital distance (AGD) is considered to be a suitable clinical marker of TDS, but the direct link between AGD and epigenetic abnormalities is still missing. Infertile men (n=10) presenting with shortened AGD and a control group of normal semen donors (n=10) with normal AGD will then be asked to provide one semen sample each. Using a flow cytometer and sorter (FACS) their spermatozoa will be sorted into populations of spermatozoa with/without DNA fragmentation or with/without chromatin decondensation. These sorted populations of spermatozoa will then be examined for differences in epigenetic imprinting differences using whole genome expression analysis. Whereas the sorting of spermatozoa will be carried out in Basel, the epigenetic analysis will be carried at the University of Geneva.

NCT ID: NCT05460585 Completed - Healthy Clinical Trials

Cerebral Oxygenation Values in Healthy Adults Volunteers Measured With RheoPatch and NIRO-200NX

Start date: June 1, 2022
Phase:
Study type: Observational

Noninvasive measurement of cerebral tissue oxygen saturation levels by near infrared spectroscopy (NIRS) is clinical routine in perioperative medicine. One of the main technical challenges of NIRS measurements is to eliminate the influence of signals of the skin and skull. A new device (RheoPatch, Luciole Medical AG, Zurich) has been developed by a company that also developed an intracranial NIRS probe, which allowed measurements directly in the brain and thus improved algorithms for elimination of the extracranial signals. The investigators aim to determine baseline values and performance of the new device (RheoPatch) compared with a more established NIRS device (NIRO-200NX, Hamamatsu Phototonics, Hamamatsu City, Japan)

NCT ID: NCT05459662 Completed - Healthy Clinical Trials

Impact of Consuming a Plant-based Enriched Meal on the Adult Gut Microbiome

Start date: May 5, 2022
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the impact of a diversified plant-based meal on the gut microbiome and its composition.

NCT ID: NCT05452161 Completed - Clinical trials for Arthroplasty, Replacement, Knee

Effects of Preoperative Education, and Follow-up Sessions of Patients With Total Hip and Knee Arthroplasty (ESIPPES)

ESIPPES
Start date: June 18, 2022
Phase: N/A
Study type: Interventional

The shortening of the length of stay implies rethinking the perioperative management (around the operative period), which precedes and immediately follows the operation, in order to ensure a good preparation of the patient and an adequate postoperative follow-up. The aim of this study is to evaluate the effect on the length of stay of adding an individualized preoperative preparation and education session to the current protocol in the musculoskeletal department at the CHUV in patients undergoing total hip or knee replacement surgery. The implementation of a targeted, low-impact immediate postoperative follow-up could contribute to improving the detection of complications, preventing avoidable readmissions, improving the management of pain and adverse events, supporting the patient and responding to difficulties encountered in the patient's living environment. However, the actual added value for the patient and for the healthcare system has yet to be specified. As patients' needs and resources vary, it would also be useful to better determine the profile of patients for whom a pre- and postoperative session provides significant added value.

NCT ID: NCT05440266 Completed - Pain Perception Clinical Trials

Electrical Intra-cutaneous Half-sine Stimulation for Optimized Preferential C-fiber Activation

Start date: May 20, 2022
Phase: N/A
Study type: Interventional

This exploratory study is to improve an established pain model by a new stimulation profile that allows preferential activation of C fibers that are of main clinical interest in chronic pain and also to generate a stable secondary hyperalgesia, which is of particular interest in the actual research of acute and chronic pain. It is to investigate if the specific activation of afferent sensory fibers and expected lower current intensities makes it more comfortable for the participant as motor neuron activation is much less pronounced at low current intensities. Therefore it compares the area under the curve (AUC) of hyperalgesia during electrical, intracutaneous 25 ms half-sine wave stimulation at a pain level of the numeric rating scale (NRS) of 6 out of 10 for 65 minutes compared to 500 µs rectangular pulses.

NCT ID: NCT05438472 Completed - Myocarditis Clinical Trials

Incidence, Patient Characteristics and Outcome of Myocarditis After COVID-19 mRNA Vaccine

MACIS
Start date: December 10, 2021
Phase:
Study type: Observational

This study evaluates the incidence, patient characteristics and outcome of myocarditis after the COVID-19 mRNA vaccination in healthcare professionals.